Insight Molecular Diagnostics Inc. Available-for-sale Securities, Gross Unrealized Gain
Insight Molecular Diagnostics Inc. (IMDX) reported Available-for-sale Securities, Gross Unrealized Gain of $90.00 thousand for the 3-month period ending 2019-06-30, per its 10-Q filed 2019-08-14.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGains · last filed 2019-08-14
- Insight Molecular Diagnostics Inc. available-for-sale securities, gross unrealized gain for the quarter ending 2019-06-30 was $90.00K, a 181.25% increase year-over-year.
- Insight Molecular Diagnostics Inc. available-for-sale securities, gross unrealized gain for the quarter ending 2019-03-31 was $178.00K, a 6.32% decline year-over-year.
- Insight Molecular Diagnostics Inc. available-for-sale securities, gross unrealized gain for the quarter ending 2018-06-30 was $32.00K.
- Insight Molecular Diagnostics Inc. available-for-sale securities, gross unrealized gain for the quarter ending 2018-03-31 was $190.00K.
| Period end | Available-for-sale Securities, Gross Unrealized Gain 3 month | Available-for-sale Securities, Gross Unrealized Gain 6 month |
|---|---|---|
| 2019-06-30 | $90.00K 10-Q · filed 2019-08-14 | $90.00K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $178.00K 10-Q · filed 2019-05-14 | |
| 2018-06-30 | $32.00K 10-Q · filed 2019-08-14 | $32.00K 10-Q · filed 2019-08-14 |
| 2018-03-31 | $190.00K 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |